Burning Rock Biotech (BNR) Treasury Shares (2021 - 2025)
Historic Treasury Shares for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to -$8.0 million.
- Burning Rock Biotech's Treasury Shares rose 1444.09% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year increase of 1444.09%. This contributed to the annual value of $8.7 million for FY2024, which is 661.57% down from last year.
- Burning Rock Biotech's Treasury Shares amounted to -$8.0 million in Q3 2025, which was up 1444.09% from -$8.5 million recorded in Q2 2025.
- Burning Rock Biotech's Treasury Shares' 5-year high stood at $9.3 million during Q4 2023, with a 5-year trough of -$9.4 million in Q3 2024.
- Moreover, its 5-year median value for Treasury Shares was -$8.3 million (2022), whereas its average is -$3.9 million.
- In the last 5 years, Burning Rock Biotech's Treasury Shares skyrocketed by 10272.31% in 2022 and then plummeted by 5010555.56% in 2023.
- Burning Rock Biotech's Treasury Shares (Quarter) stood at -$661000.0 in 2021, then skyrocketed by 1392.28% to $8.5 million in 2022, then rose by 8.65% to $9.3 million in 2023, then fell by 6.62% to $8.7 million in 2024, then crashed by 192.7% to -$8.0 million in 2025.
- Its Treasury Shares was -$8.0 million in Q3 2025, compared to -$8.5 million in Q2 2025 and -$8.6 million in Q1 2025.